Atara Biotherapeutics, Inc. (ATRA)
NASDAQ: ATRA · Real-Time Price · USD
4.760
-0.230 (-4.61%)
At close: Apr 28, 2026, 4:00 PM EDT
4.730
-0.030 (-0.63%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Atara Biotherapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | 32.69 | -85.4 | -276.13 | -228.3 | -340.14 | |
| Depreciation & Amortization | 2.12 | 5.05 | 4.83 | 5.65 | 9.35 | |
| Loss (Gain) From Sale of Assets | - | - | - | -50.24 | - | |
| Asset Writedown & Restructuring Costs | 4.13 | - | - | - | - | |
| Loss (Gain) From Sale of Investments | 0.26 | -0.24 | 0.79 | 1.02 | 1.77 | |
| Stock-Based Compensation | 9.75 | 27 | 45.39 | 53.84 | 53.87 | |
| Other Operating Activities | 4.85 | 15.83 | 16.8 | 9.06 | 2.06 | |
| Change in Accounts Receivable | 0.23 | 32.63 | 6.11 | -39.24 | 0.26 | |
| Change in Inventory | 10.66 | -4.43 | -8.12 | -1.59 | - | |
| Change in Accounts Payable | -4.24 | 0.69 | -3.13 | -9.21 | 9.07 | |
| Change in Unearned Revenue | -94.38 | -20.3 | 30.4 | -11.47 | 35.22 | |
| Change in Other Net Operating Assets | -17 | -39.54 | -9.92 | 0.03 | 8.04 | |
| Operating Cash Flow | -50.94 | -68.72 | -192.98 | -270.43 | -220.52 | |
| Capital Expenditures | - | -0.25 | -1.22 | -4.19 | -10.58 | |
| Sale of Property, Plant & Equipment | 0.95 | - | 0.03 | 94.77 | - | |
| Investment in Securities | 17.2 | 8.87 | 125.06 | 112.38 | 32.84 | |
| Investing Cash Flow | 18.15 | 8.62 | 123.87 | 202.96 | 22.26 | |
| Long-Term Debt Issued | - | - | - | 30.61 | - | |
| Long-Term Debt Repaid | -0.25 | -0.89 | -0.95 | -0.52 | -0.25 | |
| Net Debt Issued (Repaid) | -0.25 | -0.89 | -0.95 | 30.09 | -0.25 | |
| Issuance of Common Stock | 16.35 | 60.18 | 3.06 | 23.81 | 105.46 | |
| Repurchase of Common Stock | - | - | -0.09 | -0.62 | -1.24 | |
| Other Financing Activities | -0 | -0.01 | -0.01 | -0.19 | -0.02 | |
| Financing Cash Flow | 16.1 | 59.28 | 2.01 | 53.08 | 103.94 | |
| Net Cash Flow | -16.69 | -0.81 | -67.1 | -14.39 | -94.32 | |
| Free Cash Flow | -50.94 | -68.96 | -194.2 | -274.62 | -231.1 | |
| Free Cash Flow Margin | -42.18% | -53.49% | -2265.25% | -431.98% | -1136.19% | |
| Free Cash Flow Per Share | -4.00 | -9.21 | -45.84 | -67.32 | -61.68 | |
| Cash Interest Paid | 0.29 | 0.69 | 0.45 | 0.34 | 0.03 | |
| Cash Income Tax Paid | 0.19 | 0.02 | 0 | 0.02 | 0.02 | |
| Levered Free Cash Flow | -47.68 | -1.68 | -55.72 | -192.99 | -128.98 | |
| Unlevered Free Cash Flow | -45.31 | 1.21 | -52.42 | -192.76 | -128.98 | |
| Change in Working Capital | -104.74 | -30.96 | 15.34 | -61.47 | 52.58 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.